Association of mixed hematopoietic chimerism with elevated circulating autoantibodies and chronic graft-versus-host disease occurrence

被引:27
作者
Perruche, S
Marandin, A
Kleinclauss, F
Angonin, R
Fresnay, S
Baron, MH
Tiberghien, P
Saas, P
机构
[1] Univ Franche Comte, INSERM, U645, EFSB FC, F-25030 Besancon, France
[2] CHU Jean Minjoz, Serv Anat Pathol, Besancon, France
[3] CHU Jean Minjoz, Serv Radiotherapie, Besancon, France
关键词
chimerism; graft versus host disease; autoimmunity; B cells;
D O I
10.1097/01.tp.0000183878.53367.77
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Use of a reduced-intensity conditioning regimen before an allogeneic hematopoietic cell transplantation is frequently associated with an early state of mixed hematopoietic chimerism. Such a coexistence of both host and donor hematopoietic cells may influence posttransplant alloreactivity and may affect the occurrence and severity of acute and chronic graft-versus-host disease (GVHD) as well as the intensity of the graft-versus-leukemia effect. Here we evaluated the relation between chimerism state after reduced-intensity conditioning transplantation (RICT), autoantibody production, and chronic GVHD (cGVHD)-related pathology. Methods. Chimerism state, circulating anticardiolipin, and antidouble stranded DNA autoantibody (Ab) titers as well as occurrence of cGVHD-like lesions were investigated in a murine RICT model. Results. We observed a novel association between mixed chimerism state, high levels of pathogenic IgG autoantibodies, and subsequent development of cGVHD-like lesions. Furthermore, we found that the persistence of host B cells, but not dendritic cell origin or subset, was a factor associated with the appearance of cGVHD-like lesions. The implication of host B cells was confirmed by a host origin of autoantibodies. Conclusion. Recipient B cell persistence may contribute to the frequency and/or severity of cGVHD after RICT.
引用
收藏
页码:573 / 582
页数:10
相关论文
共 50 条
[11]  
FERRARA JLM, 1991, NEW ENGL J MED, V324, P667
[12]   Mouse CD11c+ B220+ Gr1+ plasmacytoid dendritic cells develop independently of the T-cell lineage [J].
Ferrero, I ;
Held, W ;
Wilson, A ;
Tacchini-Cottier, F ;
Radtke, F ;
MacDonald, HR .
BLOOD, 2002, 100 (08) :2852-2857
[13]   Can tolerogenic dendritic cells help to modulate allo-immune responses in the setting of hematopoietic cell transplantation? [J].
Fresnay, S ;
Garnache-Ottou, F ;
Plumas, J ;
Seilles, E ;
Tiberghien, P ;
Saas, P .
TRANSPLANT IMMUNOLOGY, 2003, 11 (3-4) :259-266
[14]   Persistence of recipient plasma cells and anti-donor isohaemagglutinins in patients with delayed donor erythropoiesis after major ABO incompatible non-myeloablative haematopoietic cell transplantation [J].
Griffith, LM ;
McCoy, JP ;
Bolan, CD ;
Stroncek, DF ;
Pickett, AC ;
Linton, GF ;
Lundqvist, A ;
Srinivasan, R ;
Leitman, SF ;
Childs, RW .
BRITISH JOURNAL OF HAEMATOLOGY, 2005, 128 (05) :668-675
[15]   Antibodies to DNA [J].
Hahn, BH .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (19) :1359-1368
[16]  
HAKIM F, 1998, CURRENT PROTOCOLS IM
[17]   Positive selection of natural autoreactive B cells [J].
Hayakawa, K ;
Asano, M ;
Shinton, SA ;
Gui, M ;
Allman, D ;
Stewart, CL ;
Silver, J ;
Hardy, RR .
SCIENCE, 1999, 285 (5424) :113-116
[18]   CD4+ T cells prevent skin autoimmunity during chronic autologous graft-versus-host-disease [J].
Hequet, O ;
Vocanson, M ;
Saint-Mézard, P ;
Kaiserlian, D ;
Nicolas, JF ;
Bérard, F .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (06) :872-878
[19]   Short-lived plasmablasts and long-lived plasma cells contribute to chronic humoral autoimmunity in NZB/W mice [J].
Hoyer, BF ;
Moser, K ;
Hauser, AE ;
Peddinghaus, A ;
Voigt, C ;
Eilat, D ;
Radbruch, A ;
Hiepe, F ;
Manz, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (11) :1577-1584
[20]  
ILDSTAD ST, 1986, J IMMUNOL, V136, P28